Overall, non-FLM-HCC tumors had a greater degree of YAP nuclear localization, proliferative index, and upregulation of the YAP target genes CCNE1, CTGF, and Cyr61 compared to FLM-HCC (Fig. 9). This evidence concerns the gene YAP1 and hepatocellular carcinoma.